The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of proton pump inhibitors (PPIs) on sunitinib (SU) pharmacokinetics (PK) and activity in GIST patients (pts).
 
Olivier Mir
Stock and Other Ownership Interests - Transgene
Honoraria - Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; SERVIER; Vifor Pharma
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - Pfizer; PharmaMar; Roche
 
Romain Coriat
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Novartis; Roche; Sanofi; SERVIER
 
Angelo Paci
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Pierre Fabre
 
Charles Honoré
No Relationships to Disclose
 
Matthieu Faron
No Relationships to Disclose
 
Sarah Naomie Dumont
No Relationships to Disclose
 
Philippe Terrier
No Relationships to Disclose
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - Merck Sharp & Dohme (Inst); Pierre Fabre (Inst); Sanofi (Inst)
 
Axel Le Cesne
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar